Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Actinin alpha 4 pseudogene 2" (ACTN4P2) is a **pseudogene** in the human genome. Pseudogenes are gene sequences that share similarity with known functional genes but are conventionally regarded as non-functional due to mutations that prevent them from producing a functional protein. ACTN4P2 is related to the gene encoding actinin alpha 4 (ACTN4), a protein that plays important roles in cytoskeletal organization, but ACTN4P2 itself does *not* encode a functional protein[6]. There is no evidence it acts as a therapeutic target or has established biological or disease roles. This entry is **not a therapeutic target** and is considered a **pseudogene** that does not encode a functional product or have drug relevance. Its mention as a target is likely **incorrect**[6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Actinin alpha 4 pseudogene 2 (ACTN4P2).